These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5125322)

  • 1. Iso-homovanillic acid determination in human urine.
    Comoy E; Bohuon C
    Clin Chim Acta; 1971 Dec; 35(2):369-75. PubMed ID: 5125322
    [No Abstract]   [Full Text] [Related]  

  • 2. Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease.
    Ebinger G; Adriaenssens K
    Clin Chim Acta; 1973 Nov; 48(4):427-31. PubMed ID: 4761590
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation and determination of urinary homovanillic acid and iso-homovanillic acid by gas-liquid chromatography and electron capture detection.
    Dziedzic SW; Dziedzic LB; Gitlow SE
    J Lab Clin Med; 1973 Nov; 82(5):829-35. PubMed ID: 4746822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of homoprotocatechic acid in urine by a radioisotopic method].
    Comoy E; Bohuon C
    Clin Chim Acta; 1972 Jan; 36(1):207-12. PubMed ID: 5007702
    [No Abstract]   [Full Text] [Related]  

  • 5. Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
    Molnár G; Fodor A
    Ther Hung; 1973; 21(1):35-40. PubMed ID: 4792890
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple and rapid gas chromatography for determining 3,4-dihydroxyphenylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid in urine from patients with parkinsonism treated with L-3,4-dihydroxyphenylalanine.
    Fukaya J; Imai K; Tamura Z
    Clin Chim Acta; 1971 Jul; 33(2):470-2. PubMed ID: 5119325
    [No Abstract]   [Full Text] [Related]  

  • 8. Assay of 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid by liquid chromatography with electrochemical detection.
    Morrisey JL; Shihabi ZK
    Clin Chem; 1979 Dec; 25(12):2045-7. PubMed ID: 509705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a screening test for L-dopa and its metabolites in urine.
    Routh JI; Bannow RE
    Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
    Mrochek JE; Dinsmore SR; Ohrt DW
    Clin Chem; 1973 Aug; 19(8):927-36. PubMed ID: 4720815
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
    Jones DG; Lenman JA; Robertson MA; Turnbull MJ
    Br J Pharmacol; 1972 Feb; 44(2):386P-387P. PubMed ID: 4668639
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Eichhorn F; Rutenberg A; Kott E
    Clin Chem; 1971 Apr; 17(4):296-300. PubMed ID: 5552365
    [No Abstract]   [Full Text] [Related]  

  • 13. 2,3,5-Trihydroxyphenylacetic acid. A metabolite of L-3,4-dihydroxyphenylalanine.
    Wada GH; Fellman JH
    Biochemistry; 1973 Dec; 12(25):5212-7. PubMed ID: 4799943
    [No Abstract]   [Full Text] [Related]  

  • 14. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid homovanillic acid and iso-homovanillic acid: a gas-liquid chromatographic method.
    Dziedzic SW; Gitlow SE
    J Neurochem; 1974 Mar; 22(3):333-5. PubMed ID: 4829959
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of L-dopa therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease.
    Boulton AA; Marjerrison GL
    Nature; 1972 Mar; 236(5341):76-8. PubMed ID: 4553458
    [No Abstract]   [Full Text] [Related]  

  • 18. EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
    Marjerrison G; Boulton AA; Rajput AH
    Dis Nerv Syst; 1972 Mar; 33(3):164-9. PubMed ID: 5022451
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the excretion of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in neuroblastoma and other neural tumors].
    von STUDNITZ
    Klin Wochenschr; 1962 Feb; 40():163-7. PubMed ID: 13917983
    [No Abstract]   [Full Text] [Related]  

  • 20. Variation of levodopa metabolism with gastrointestinal absorption site.
    Sandler M; Ruthven CR; Goodwin BL; Hunter KR; Stern GM
    Lancet; 1974 Feb; 1(7851):238-40. PubMed ID: 4130247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.